CAN-FITE BIOPHARMA LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.7 ILa | 0.00% |
|
-3.57% | +3.85% |
| 05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
| 05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Biopharmaceuticals | 0.00% | -3.57% | +3.85% | -20.59% | -92.68% | 10.88M |  | |  |
- Stock Market
- Equities
- CANF Stock
- Charts Can-Fite BioPharma Ltd.
- Relative Strength Chart